期刊文献+

温阳化浊通络方对系统性硬化病小鼠体内血管内皮生长因子、结缔组织生长因子与内皮素-1水平的影响 被引量:6

Effect of Wenyang Huazhuo Tongluo Decoction on VEGF,CTGF and ET-1 Levels in Systemic Sclerosis Mice
下载PDF
导出
摘要 为探讨温阳化浊通络方对系统性硬化病(SSc)小鼠血清中VEGF、CTGF与ET-1水平的影响,运用ELISA法检测小鼠血清中VEGF、CTGF、ET-1的含量。将SPF级C3H/He小鼠75只,造模成功后随机分为正常组、PBS组、模型组。正常组为每天胃内灌注等量生理盐水;PBS组为PBS 0.1 mL/d,连续皮下注射3周,每天胃内灌注等量生理盐水;模型组为每天胃内灌注等量生理盐水;模型+温阳化浊通络方组为每天胃内灌注等量温阳化浊通络方煎;模型+XAV939组为每天给以XAV939(10mg/kg,i.p)。结果:模型+温阳化浊通络方组和模型+XAV939组精神恢复良好、体重增加、背部表皮较硬、出现少数毛囊,血清中VEGF、CTGF、ET-1的含量均有所下调,两组比较无统计学差异(P>0.05);与模型组相比差异明显(P<0.01)。说明温阳化浊通络方可调控SSc小鼠血清中VEGF、CTGF与ET-1的表达,改善皮肤纤维化的病理损伤,阻止纤维化进展。 To investigate the Wenyang Huazhuo Tongluo decoction on systemic sclerosis( SSc) in mice serum VEGF,CTGF and ET-1 level,the content of VEGF,CTGF and ET-1 in the serum of mice was detected by ELISA.75 SPF C3H/He mice were randomly divided into the normal group,the PBS group and the model group after the success of the model. Normal group: Daily intragastric perfusion of equal amount of saline; Group PBS: PBS 0. 1 mL/d,continuous subcutaneous injection for 3 weeks,and intragastric perfusion of equal amount of normal saline every day; Model group: Daily intragastric perfusion of equal amount of saline; Model + Wenyang Huazhuo Tongluo decoction group: Daily intragastric infusion with Wenyang Huazhuo Tongluo decoction decoction; Model + XAV939 group: XAV939( 10 mg/kg,i. p) per day. Show that model + Wenyang Huazhuo Tongluo decoction group and model + XAV939 group spirit of good recovery,gain weight,The back of the skin is hard and a few hair follicles appear. The contents of VEGF,CTGF and ET-1 in the serum were all downregulated. There was no statistical difference between the two groups( P〈0. 05); Compared with the model group,the difference is obvious( P〈0. 01).Wenyang Huazhuo Tongluo decoction can express VEGF,CTGF and ET-1 in serum of SSc mice in control,to improve the pathological damage of skin fibrosis and prevent the progress of fibrosis.
作者 张瓅方 王倩 杨雷 刘暖 叶松山 卞华 ZHANG Li-fang;WANG Qian;YANG Lie;LIU Nuan;YE Song-shan;BIAN Hua(Henan Key Laboratory of ZHANG Zhong,jing Formulae and Herbs for hnmunoregulation,Nanyang Institute of Technology,Nanyang 473004,China)
出处 《科学技术与工程》 北大核心 2018年第15期215-219,共5页 Science Technology and Engineering
基金 国家自然科学基金(81373627) 河南省中医内科学重点学科支撑课题(豫教高2012-186) 河南省高等学校特色专业建设项目(教高2013-5823)资助
关键词 温阳化浊通络方 系统性硬化病 纤维化 VEGF CTGF ET-1 Wenyang Huazhuo Tongluo decoction systemic sclerosis fibrosis VEGF CTGFET-1
  • 相关文献

参考文献5

二级参考文献39

  • 1吕小岩,李明,翁孟武.系统性硬皮病患者成纤维细胞转化生长因子β1与Ⅰ型胶原mRNA表达的研究[J].中华皮肤科杂志,2003,36(9):490-492. 被引量:6
  • 2苏立德,颜纪贤.雷公藤多甙治疗系统性硬皮病临床观察[J].中国中西医结合杂志,1994,14(4):234-235. 被引量:21
  • 3朱铭华.浅谈皮肤病从脾论治[J].江苏中医药,2005,26(8):42-43. 被引量:6
  • 4杨映波 王正国 等.100例我国正常人循环内皮细胞的数量及形态学研究[J].中华医学检验杂志,1993,16(1):36-38.
  • 5Subcomitee of Scleroderma Criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee.Preliminary criteria for the dassification of systemic sclerosis (sderoderma) [J] . Arthritis Rheum, 1980, 23 (5): 581-590.
  • 6ClementsP, LachenbruchP, Seibokld J, etal.lntcrand int-raobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis [J] .J Rheumatol 1995, 22 (7) : 1281 - 1285.
  • 7Kahan A, Amor B, Menkes CJ, et al.Recombinant interferongamma in the trestment of systemic sclerosis [J] . Am JMed, 1989, 87 (3) : 273 - 277.
  • 8Schmidt J, Launay D, Soudan B, et al. Assessment of plasma endothelin level measurement in systemic sclerosis [J] . Rev Med Interne, 2007, 8 (6): 371 -376.
  • 9Subcomitee of Scleroderma Criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee.Preliminary criteria for the classification of systemic sclerosis(scleroderma)[J].Arthritis Rheum,1980,23(5):581-590.
  • 10Varga JA,Trojanowska M.Fibrosis in systemic sclerosis[J].Rheum Dis Clin North Am,2008,34(1):115-143.

共引文献55

同被引文献44

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部